Autologous hematopoietic stem cell transplantation for autoimmune diseases
Identifieur interne : 001725 ( PascalFrancis/Curation ); précédent : 001724; suivant : 001726Autologous hematopoietic stem cell transplantation for autoimmune diseases
Auteurs : A. Gratwohl [Suisse] ; J. Passweg [Suisse] ; C. Bocelli-Tyndall [Suisse] ; A. Fassas [Grèce] ; J. M. Van Laar [Pays-Bas] ; D. Farge [France] ; M. Andolina [Italie] ; R. Arnold [Allemagne] ; E. Carreras [Espagne] ; J. Finke [Allemagne] ; I. Kötter [Allemagne] ; T. Kozak [République tchèque] ; I. Lisukov [Russie] ; B. Löwenberg [Pays-Bas] ; A. Marmont [Italie] ; J. Moore [Australie] ; R. Saccardi [Italie] ; J. A. Snowden [Royaume-Uni] ; F. Van Den Hoogen [Pays-Bas] ; N. M. Wulffraat [Pays-Bas] ; X. W. Zhao [République populaire de Chine] ; A. Tyndall [Suisse]Source :
- Bone marrow transplantation : (Basingstoke) [ 0268-3369 ] ; 2005.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Cellule souche.
English descriptors
- KwdEn :
Abstract
Experimental data and early phase I/II studies suggest that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest progression of severe autoimmune diseases. We have evaluated the toxicity and disease response in 473 patients with severe autoimmune disease treated with autologous HSCT between 1995 and 2003, from 110 centers participating in the European Group for Blood and Marrow Transplantation (EBMT) autoimmune disease working party database. Survival, transplant-related mortality, treatment response and disease progression were assessed. In all, 420 patients (89%; 86±4% at 3 years, median follow-up 20 months) were alive, 53 (11%) had died from transplant-related mortality (N=31; 7±3% at 3 years) or disease progression (N= 22; 9±4% at 3 years). Of 370 patients, 299 evaluable for response (81%) showed a treatment response, which was sustained in 213 (71% of responders). Response was associated with disease (P<0.001), was better in patients who received cyclophosphamide during mobilization (relative risk (RR)3.28 (1.57-6.83)) and was worse with increasing age (>40 years, RR0.29 (0.11-0.82)). Disease progression was associated with disease (P<0.001) and conditioning intensity (high intensity, RR1; intermediate intensity, RR1.81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.
pA |
|
---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004978
Links to Exploration step
Pascal:05-0217360Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Autologous hematopoietic stem cell transplantation for autoimmune diseases</title>
<author><name sortKey="Gratwohl, A" sort="Gratwohl, A" uniqKey="Gratwohl A" first="A." last="Gratwohl">A. Gratwohl</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Passweg, J" sort="Passweg, J" uniqKey="Passweg J" first="J." last="Passweg">J. Passweg</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Bocelli Tyndall, C" sort="Bocelli Tyndall, C" uniqKey="Bocelli Tyndall C" first="C." last="Bocelli-Tyndall">C. Bocelli-Tyndall</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Fassas, A" sort="Fassas, A" uniqKey="Fassas A" first="A." last="Fassas">A. Fassas</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>George Papanicolaou Hospital</s1>
<s2>Thessaloniki</s2>
<s3>GRC</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Grèce</country>
</affiliation>
</author>
<author><name sortKey="Van Laar, J M" sort="Van Laar, J M" uniqKey="Van Laar J" first="J. M." last="Van Laar">J. M. Van Laar</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Leiden University Medical Center</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Farge, D" sort="Farge, D" uniqKey="Farge D" first="D." last="Farge">D. Farge</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Hôpital St Louis</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Andolina, M" sort="Andolina, M" uniqKey="Andolina M" first="M." last="Andolina">M. Andolina</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Istituto per l'Infanzia Burlo Garofolo</s1>
<s2>Trieste</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Arnold, R" sort="Arnold, R" uniqKey="Arnold R" first="R." last="Arnold">R. Arnold</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Universitätsklinikum Charité</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Carreras, E" sort="Carreras, E" uniqKey="Carreras E" first="E." last="Carreras">E. Carreras</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Finke, J" sort="Finke, J" uniqKey="Finke J" first="J." last="Finke">J. Finke</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Klinikum der Albert-Ludwigs Universität Freiburg</s1>
<s2>Freiburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Kotter, I" sort="Kotter, I" uniqKey="Kotter I" first="I." last="Kötter">I. Kötter</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Medizinische Universitdtsklinik</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Kozak, T" sort="Kozak, T" uniqKey="Kozak T" first="T." last="Kozak">T. Kozak</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>University Hospital Krulovske Vinohrady</s1>
<s2>Prague</s2>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>République tchèque</country>
</affiliation>
</author>
<author><name sortKey="Lisukov, I" sort="Lisukov, I" uniqKey="Lisukov I" first="I." last="Lisukov">I. Lisukov</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Institute of Clinical Immunology</s1>
<s2>Novosibirsk</s2>
<s3>RUS</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Russie</country>
</affiliation>
</author>
<author><name sortKey="Lowenberg, B" sort="Lowenberg, B" uniqKey="Lowenberg B" first="B." last="Löwenberg">B. Löwenberg</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Erasmus University Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Marmont, A" sort="Marmont, A" uniqKey="Marmont A" first="A." last="Marmont">A. Marmont</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Ospedale San Martino</s1>
<s2>Genova</s2>
<s3>ITA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Moore, J" sort="Moore, J" uniqKey="Moore J" first="J." last="Moore">J. Moore</name>
<affiliation wicri:level="1"><inist:fA14 i1="15"><s1>St Vincents Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author><name sortKey="Saccardi, R" sort="Saccardi, R" uniqKey="Saccardi R" first="R." last="Saccardi">R. Saccardi</name>
<affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Ospedale di Careggi</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Snowden, J A" sort="Snowden, J A" uniqKey="Snowden J" first="J. A." last="Snowden">J. A. Snowden</name>
<affiliation wicri:level="1"><inist:fA14 i1="17"><s1>Sheffield Teaching Hospitals NHS Trust</s1>
<s2>Sheffield</s2>
<s3>GBR</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Van Den Hoogen, F" sort="Van Den Hoogen, F" uniqKey="Van Den Hoogen F" first="F." last="Van Den Hoogen">F. Van Den Hoogen</name>
<affiliation wicri:level="1"><inist:fA14 i1="18"><s1>University Medical Center St Radboud</s1>
<s2>Nijmegen</s2>
<s3>NLD</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Wulffraat, N M" sort="Wulffraat, N M" uniqKey="Wulffraat N" first="N. M." last="Wulffraat">N. M. Wulffraat</name>
<affiliation wicri:level="1"><inist:fA14 i1="19"><s1>University Hospital for Children</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Zhao, X W" sort="Zhao, X W" uniqKey="Zhao X" first="X. W." last="Zhao">X. W. Zhao</name>
<affiliation wicri:level="1"><inist:fA14 i1="20"><s1>The Third People Hospital of Zhengzhou</s1>
<s2>Zhengzhou</s2>
<s3>CHN</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Tyndall, A" sort="Tyndall, A" uniqKey="Tyndall A" first="A." last="Tyndall">A. Tyndall</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0217360</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0217360 INIST</idno>
<idno type="RBID">Pascal:05-0217360</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004978</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001725</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Autologous hematopoietic stem cell transplantation for autoimmune diseases</title>
<author><name sortKey="Gratwohl, A" sort="Gratwohl, A" uniqKey="Gratwohl A" first="A." last="Gratwohl">A. Gratwohl</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Passweg, J" sort="Passweg, J" uniqKey="Passweg J" first="J." last="Passweg">J. Passweg</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Bocelli Tyndall, C" sort="Bocelli Tyndall, C" uniqKey="Bocelli Tyndall C" first="C." last="Bocelli-Tyndall">C. Bocelli-Tyndall</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Fassas, A" sort="Fassas, A" uniqKey="Fassas A" first="A." last="Fassas">A. Fassas</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>George Papanicolaou Hospital</s1>
<s2>Thessaloniki</s2>
<s3>GRC</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Grèce</country>
</affiliation>
</author>
<author><name sortKey="Van Laar, J M" sort="Van Laar, J M" uniqKey="Van Laar J" first="J. M." last="Van Laar">J. M. Van Laar</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Leiden University Medical Center</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Farge, D" sort="Farge, D" uniqKey="Farge D" first="D." last="Farge">D. Farge</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Hôpital St Louis</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Andolina, M" sort="Andolina, M" uniqKey="Andolina M" first="M." last="Andolina">M. Andolina</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Istituto per l'Infanzia Burlo Garofolo</s1>
<s2>Trieste</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Arnold, R" sort="Arnold, R" uniqKey="Arnold R" first="R." last="Arnold">R. Arnold</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Universitätsklinikum Charité</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Carreras, E" sort="Carreras, E" uniqKey="Carreras E" first="E." last="Carreras">E. Carreras</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Finke, J" sort="Finke, J" uniqKey="Finke J" first="J." last="Finke">J. Finke</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Klinikum der Albert-Ludwigs Universität Freiburg</s1>
<s2>Freiburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Kotter, I" sort="Kotter, I" uniqKey="Kotter I" first="I." last="Kötter">I. Kötter</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Medizinische Universitdtsklinik</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Kozak, T" sort="Kozak, T" uniqKey="Kozak T" first="T." last="Kozak">T. Kozak</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>University Hospital Krulovske Vinohrady</s1>
<s2>Prague</s2>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>République tchèque</country>
</affiliation>
</author>
<author><name sortKey="Lisukov, I" sort="Lisukov, I" uniqKey="Lisukov I" first="I." last="Lisukov">I. Lisukov</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Institute of Clinical Immunology</s1>
<s2>Novosibirsk</s2>
<s3>RUS</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Russie</country>
</affiliation>
</author>
<author><name sortKey="Lowenberg, B" sort="Lowenberg, B" uniqKey="Lowenberg B" first="B." last="Löwenberg">B. Löwenberg</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Erasmus University Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Marmont, A" sort="Marmont, A" uniqKey="Marmont A" first="A." last="Marmont">A. Marmont</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Ospedale San Martino</s1>
<s2>Genova</s2>
<s3>ITA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Moore, J" sort="Moore, J" uniqKey="Moore J" first="J." last="Moore">J. Moore</name>
<affiliation wicri:level="1"><inist:fA14 i1="15"><s1>St Vincents Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author><name sortKey="Saccardi, R" sort="Saccardi, R" uniqKey="Saccardi R" first="R." last="Saccardi">R. Saccardi</name>
<affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Ospedale di Careggi</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Snowden, J A" sort="Snowden, J A" uniqKey="Snowden J" first="J. A." last="Snowden">J. A. Snowden</name>
<affiliation wicri:level="1"><inist:fA14 i1="17"><s1>Sheffield Teaching Hospitals NHS Trust</s1>
<s2>Sheffield</s2>
<s3>GBR</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Van Den Hoogen, F" sort="Van Den Hoogen, F" uniqKey="Van Den Hoogen F" first="F." last="Van Den Hoogen">F. Van Den Hoogen</name>
<affiliation wicri:level="1"><inist:fA14 i1="18"><s1>University Medical Center St Radboud</s1>
<s2>Nijmegen</s2>
<s3>NLD</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Wulffraat, N M" sort="Wulffraat, N M" uniqKey="Wulffraat N" first="N. M." last="Wulffraat">N. M. Wulffraat</name>
<affiliation wicri:level="1"><inist:fA14 i1="19"><s1>University Hospital for Children</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Zhao, X W" sort="Zhao, X W" uniqKey="Zhao X" first="X. W." last="Zhao">X. W. Zhao</name>
<affiliation wicri:level="1"><inist:fA14 i1="20"><s1>The Third People Hospital of Zhengzhou</s1>
<s2>Zhengzhou</s2>
<s3>CHN</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Tyndall, A" sort="Tyndall, A" uniqKey="Tyndall A" first="A." last="Tyndall">A. Tyndall</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Bone marrow transplantation : (Basingstoke)</title>
<title level="j" type="abbreviated">Bone marrow transplant. : (Basingstoke)</title>
<idno type="ISSN">0268-3369</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Bone marrow transplantation : (Basingstoke)</title>
<title level="j" type="abbreviated">Bone marrow transplant. : (Basingstoke)</title>
<idno type="ISSN">0268-3369</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Autograft</term>
<term>Autoimmune disease</term>
<term>Hematology</term>
<term>Hematopoietic cell</term>
<term>Immunosuppression</term>
<term>Stem cell</term>
<term>Survival</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Autogreffe</term>
<term>Cellule hématopoïétique</term>
<term>Cellule souche</term>
<term>Maladie autoimmune</term>
<term>Immunodépression</term>
<term>Survie</term>
<term>Traitement</term>
<term>Hématologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Cellule souche</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Experimental data and early phase I/II studies suggest that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest progression of severe autoimmune diseases. We have evaluated the toxicity and disease response in 473 patients with severe autoimmune disease treated with autologous HSCT between 1995 and 2003, from 110 centers participating in the European Group for Blood and Marrow Transplantation (EBMT) autoimmune disease working party database. Survival, transplant-related mortality, treatment response and disease progression were assessed. In all, 420 patients (89%; 86±4% at 3 years, median follow-up 20 months) were alive, 53 (11%) had died from transplant-related mortality (N=31; 7±3% at 3 years) or disease progression (N= 22; 9±4% at 3 years). Of 370 patients, 299 evaluable for response (81%) showed a treatment response, which was sustained in 213 (71% of responders). Response was associated with disease (P<0.001), was better in patients who received cyclophosphamide during mobilization (relative risk (RR)3.28 (1.57-6.83)) and was worse with increasing age (>40 years, RR0.29 (0.11-0.82)). Disease progression was associated with disease (P<0.001) and conditioning intensity (high intensity, RR1; intermediate intensity, RR1.81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0268-3369</s0>
</fA01>
<fA02 i1="01"><s0>BMTRE9</s0>
</fA02>
<fA03 i2="1"><s0>Bone marrow transplant. : (Basingstoke)</s0>
</fA03>
<fA05><s2>35</s2>
</fA05>
<fA06><s2>9</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Autologous hematopoietic stem cell transplantation for autoimmune diseases</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>GRATWOHL (A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>PASSWEG (J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BOCELLI-TYNDALL (C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>FASSAS (A.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>VAN LAAR (J. M.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>FARGE (D.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>ANDOLINA (M.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>ARNOLD (R.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>CARRERAS (E.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>FINKE (J.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>KÖTTER (I.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>KOZAK (T.)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>LISUKOV (I.)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>LÖWENBERG (B.)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>MARMONT (A.)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>MOORE (J.)</s1>
</fA11>
<fA11 i1="17" i2="1"><s1>SACCARDI (R.)</s1>
</fA11>
<fA11 i1="18" i2="1"><s1>SNOWDEN (J. A.)</s1>
</fA11>
<fA11 i1="19" i2="1"><s1>VAN DEN HOOGEN (F.)</s1>
</fA11>
<fA11 i1="20" i2="1"><s1>WULFFRAAT (N. M.)</s1>
</fA11>
<fA11 i1="21" i2="1"><s1>ZHAO (X. W.)</s1>
</fA11>
<fA11 i1="22" i2="1"><s1>TYNDALL (A.)</s1>
</fA11>
<fA14 i1="01"><s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>George Papanicolaou Hospital</s1>
<s2>Thessaloniki</s2>
<s3>GRC</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Leiden University Medical Center</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Hôpital St Louis</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Istituto per l'Infanzia Burlo Garofolo</s1>
<s2>Trieste</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Universitätsklinikum Charité</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Klinikum der Albert-Ludwigs Universität Freiburg</s1>
<s2>Freiburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Medizinische Universitdtsklinik</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>University Hospital Krulovske Vinohrady</s1>
<s2>Prague</s2>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Institute of Clinical Immunology</s1>
<s2>Novosibirsk</s2>
<s3>RUS</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>Erasmus University Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>Ospedale San Martino</s1>
<s2>Genova</s2>
<s3>ITA</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="15"><s1>St Vincents Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA14 i1="16"><s1>Ospedale di Careggi</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="17"><s1>Sheffield Teaching Hospitals NHS Trust</s1>
<s2>Sheffield</s2>
<s3>GBR</s3>
<sZ>18 aut.</sZ>
</fA14>
<fA14 i1="18"><s1>University Medical Center St Radboud</s1>
<s2>Nijmegen</s2>
<s3>NLD</s3>
<sZ>19 aut.</sZ>
</fA14>
<fA14 i1="19"><s1>University Hospital for Children</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>20 aut.</sZ>
</fA14>
<fA14 i1="20"><s1>The Third People Hospital of Zhengzhou</s1>
<s2>Zhengzhou</s2>
<s3>CHN</s3>
<sZ>21 aut.</sZ>
</fA14>
<fA17 i1="01" i2="1"><s1>Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)</s1>
<s3>EUR</s3>
</fA17>
<fA17 i1="02" i2="1"><s1>Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)</s1>
<s3>EUR</s3>
</fA17>
<fA20><s1>869-879</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>21176</s2>
<s5>354000125987370030</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>50 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>05-0217360</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Bone marrow transplantation : (Basingstoke)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Experimental data and early phase I/II studies suggest that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest progression of severe autoimmune diseases. We have evaluated the toxicity and disease response in 473 patients with severe autoimmune disease treated with autologous HSCT between 1995 and 2003, from 110 centers participating in the European Group for Blood and Marrow Transplantation (EBMT) autoimmune disease working party database. Survival, transplant-related mortality, treatment response and disease progression were assessed. In all, 420 patients (89%; 86±4% at 3 years, median follow-up 20 months) were alive, 53 (11%) had died from transplant-related mortality (N=31; 7±3% at 3 years) or disease progression (N= 22; 9±4% at 3 years). Of 370 patients, 299 evaluable for response (81%) showed a treatment response, which was sustained in 213 (71% of responders). Response was associated with disease (P<0.001), was better in patients who received cyclophosphamide during mobilization (relative risk (RR)3.28 (1.57-6.83)) and was worse with increasing age (>40 years, RR0.29 (0.11-0.82)). Disease progression was associated with disease (P<0.001) and conditioning intensity (high intensity, RR1; intermediate intensity, RR1.81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B27D02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Autogreffe</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Autograft</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Autoinjerto</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Cellule hématopoïétique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Hematopoietic cell</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Célula hematopoyética</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Cellule souche</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Stem cell</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Célula primitiva</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Maladie autoimmune</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Autoimmune disease</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Enfermedad autoinmune</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Immunodépression</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Immunosuppression</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Inmunodepresión</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Survie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Survival</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Sobrevivencia</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Traitement</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Treatment</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Hématologie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Hematology</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hematología</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Greffe</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Graft</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Injerto</s0>
<s5>37</s5>
</fC07>
<fN21><s1>150</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001725 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001725 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PascalFrancis |étape= Curation |type= RBID |clé= Pascal:05-0217360 |texte= Autologous hematopoietic stem cell transplantation for autoimmune diseases }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |